3UKROPEC J, RESELAND J E, GASPERIKOVA D, eta|. The hypotrig|yceridemic effect of dietary n-3 FA is associated with increased beta-oxidation and reduced leptin expression [ J ]. Lipids, 2003 (38) :1023.
4MADSEN L, PETERSEN R K, KRISTIANSEN K. Regulation of adipocyte differentiation and function by polyunsaturated fatty acids [ J ]. Bioehim BiophysActa, 2005 (1740) :266.
6L1CHTENSTEIN A H, SCHWAB U S. Relationship of dietary fat to glucose metabolism [ J ]. Atherosclerosis, 2000, 150(2): 227-243.
7HUNNICUTT J W, HARDY R W, WILLIFORD J, et al. Saturated fatty acid-induced insulin resistance in rat adipocytes [ J ]. Diabetes, 1994, 43 (4) : 540 -545.
8VESSBY B, UUSITUPA M, HERMANSEN K, et al. Substituting dietary saturated for monounsaturated fat impairs insulin sensitivity in healthy men and women : the KANWU study [ J]. Diabetologia, 2001, 44 (3) : 312-319.
9MA Y, OLENDZKI B C, HAFNER A R, et al. Low carbohydrate and high fat intake among adult patients with poorly controlled type 2 diabetes mellitus [ J ]. Nutrition, 2006, 22 (11.-12) : 1129 -1136.
10GALGANI J E, UAUY R D, AGUIRRE C A, et al. Effect of the dietary fat quality on insulin sensitivity [J]. BrJ Nutr, 2008, 100(3): 471-479.
7Scaglioni S, Verduic E, Salvioni M et al. Plasma long - chain and the degree of obesity in Italian children [ J] . Acta Paediatr, 2006, 95 (8) : 964.
8Ukropec J, Reseland JE, Gasperikova D et al. The hypotriglyceridemic effect of dietary n - 3 FA is associated with increased beta - oxidation and reduced leptin expression [J] . Lipids, 2003, 38:1023.
9Madsen L, Petersen RK, Kristiansen K. Regulation of adipocyte differentiation and function by polyunsaturated fatty acids [J] . Biochim Biophys Acta. 2005, 1740:266.
10Houseknecht KL, Cole BM, Steele PJ. Peroxisome proliferator- activated receptor gamma (PPAR gamma) and its ligands: a review [J] . Domest Anita Endocrinol, 2002, 22 (1) : 1.
4Meigs JB, Wilson PW, Fox CX, et al. Body mass index, metabolic syndrome, and risk of type 2 diabetes or cardiovascular disease [J]. J Clin Endocrinol Metab, 2006,91 ( 8 ): 2906-2912.
5Ortega FB, Lee DC, Katzmarzyk PT, et al. The intriguing metabolically healthy but obese phenotype: cardiovascular prognosis and role of fitness[J ]. Eur Heart J,2013,34(5 ):389-397.
6Stefan N, Hating HU, Hu FB, et al. Metabolically healthy obesity: epidemiology, mechanisms, and clinical implications [ J ]. Lancet Diabetes Endocrinol, 2013,1(2): 152-162.
7Messier V, Karelis AD, Prud'Homme De, et al. Identifying metabolically healthy hut obese individuals in sedentary postmenopausal women [J]. Obesity (Silver Spring) ,2010,18 (5): 911-917.
8Ye Y, Bao Y, Hou X, et al. Identification of waist eircurnference cutoffs for abdominal obesity in the Chinese population: a 7.8-year follow-up study in the Shanghai urban area[J]. Int J Obes (Lond), 2009, 33(9): 1058-1062.
9Sadeghi M, Pourmoghaddas Z, Hekmatnia A, et al. Abdominal fat distribution and serum lipids in patients with and without coronary heart disease[J]. Arch Iran Med, 2013,16(3 ):149-153.
10Lonnqivist F, Thome A, Nilsell K, et al. A pathogenic role of visceral fat beta 3-adrenoceptors in obesity [ J ]. J Clin Invest, 1995,95 ( 3 ): 1109-1116.
